:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40976299/a7ffd4b45dff0f660b59dc38a50b261c_wm.png)
C-C motif glycoprotein ligand 5 (CCL5) and its GPCR CCR5: Macromolecular game-changers in cancer biology.
Summary: Imagine your body has a chemical messaging system that tells immune cells where to go. One of these important messengers is called CCL5. It acts like a homing beacon by attaching to a receiver on cells called CCR5. In a healthy body, this system helps fight off infections.
But in cancer, tumors can hijack this system! The cancer uses CCL5 to build a shield of "bad" immune cells around itself, grow new blood vessels, and spread to other parts of the body. It even helps the tumor resist cancer drugs. Scientists are now studying exactly how this hijacking works. If they can understand the shape and function of these molecules, they might be able to create new treatments to block the signal and help the body fight cancer.
Tags
Neoplasm Metastasis
Death
Neoplasms
Epithelial-Mesenchymal Transition
Receptors, G-Protein-Coupled
Chemokine CCL5
Tumor-Associated Macrophages
Myeloid-Derived Suppressor Cells